Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels

Brain Research

Volumn 1190, Issue 1, 2008, Pages 39-48

  Bongiovanni, Rodolfo ^a   Newbould, Erica ^a   Jaskiw, George E ^a,b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

DOPA; Dopamine; Norepinephrine; NSD 1015; Prefrontal cortex; Schizophrenia

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; AMINO ACID; CATECHOLAMINE; DESIPRAMINE; DOPAMINE; NORADRENALIN TRANSPORTER; TYROSINE;

AMINO ACID BRAIN LEVEL; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CATECHOLAMINE BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINE METABOLISM; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; DESIPRAMINE; DIHYDROXYPHENYLALANINE; DOPAMINE; MALE; MICRODIALYSIS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE;

RATTUS;

EID: 37549013794     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.10.079     Document Type: Article

References (84)

1. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., and Lewis D.A. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry 156 (1999) 1580-1589
2. Akil M., Edgar C.L., Pierri J.N., Casali S., and Lewis D.A. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol. Psychiatry 47 (2000) 361-370
3. Bannon M.J., Bunney E.B., and Roth R.H. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems. Brain Res. 218 (1981) 376-382
4. Bert L., Favale D., Jego G., Greve P., Guilloux J.P., Guiard B.P., Gardier A.M., Suaud-Chagny M.F., and Lestage P. Rapid and precise method to locate microdialysis probe implantation in the rodent brain. J. Neurosci. Methods 140 (2004) 53-57
5. Biggio G., Porceddu M.L., and Gessa G.L. Decrease of homovanillic, dihydroxyphenylacetic acid and cyclic-adenosine-3′,5′-monophosphate content in the rat caudate nucleus induced by the acute administration of an aminoacid mixture lacking tyrosine and phenylalanine. J. Neurochem. 26 (1976) 1253-1255
6. Bitar M., Koulu M., Rapoport S.I., and Linnoila M. Diabetes-induced alteration in brain monoamine metabolism in rats. J. Pharmacol. Exp. Ther. 236 (1986) 432-437
7. Bjerkenstedt L., Farde L., Terenius L., Edman G., Venizelos N., and Wiesel F.A. Support for limited brain availability of tyrosine in patients with schizophrenia. Int. J. Neuropsychopharmacol. 9 (2006) 247-255
8. Bongiovanni R., Yamamoto B.K., and Jaskiw G.E. Improved method for the measurement of large neutral amino acids in biological matrices. J. Chromatogr., B, Biomed. Sci. Appl. 754 (2001) 369-376
9. Bongiovanni R., Kirkbride B., Walmire P., and Jaskiw G.E. Tyrosine administration does not affect desipramine-induced dopamine levels as measured in vivo in prefrontal cortex. Brain Res. 1054 (2005) 203-206
10. Bongiovanni R., Young D., Newbould E., and Jaskiw G.E. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine. Brain Res. 1115 (2006) 26-36
11. Bradberry C.W., Karasic D.H., Deutch A.Y., and Roth R.H. Regionally-specific alterations in mesotelencephalic dopamine synthesis in diabetic rats: association with precursor tyrosine. J. Neural Transm. 78 (1989) 221-229
12. Carboni E., Tanda G., and Di Chiara G. Extracellular striatal concentrations of endogenous 3,4-dihydroxyphenylalanine in the absence of a decarboxylase inhibitor: a dynamic index of dopamine synthesis in vivo. J. Neurochem. 59 (1992) 2230-2236
13. Carboni E., Silvagni A., Vacca C., and Di Chiara G. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex. J. Neurochem. 96 (2006) 473-481
14. Carlsson A., Davis J.N., Kehr W., Lindqvist M., and Atack C.V. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275 (1972) 153-168
15. Cass W.A., and Gerhardt G.A. In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens. J. Neurochem. 65 (1995) 201-207
16. Chen R., Wei J., Fowler S.C., and Wu J.Y. Demonstration of functional coupling between dopamine synthesis and its packaging into synaptic vesicles. J. Biomed. Sci. 10 (2003) 774-781
17. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology (2002), Oxford University Press, New York
18. Descarries L., Lemay B., Doucet G., and Berger B. Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience 21 (1987) 807-824
19. Di Chiara G., Tanda G.L., Frau R., and Carboni E. Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers. Neurochem. Int. 20 Suppl (1992) 231S-235S
20. Dyck L.E. Effect of decarboxylase inhibitors on brain p-tyrosine levels. Biochem. Pharmacol. 36 (1987) 1373-1376
21. Emson P.C., and Koob G.F. The origin and distribution of dopamine-containing afferents to the rat frontal cortex. Brain Res. 142 (1978) 249-267
22. Fernstrom J.D. Role of precursor availability in control of monoamine biosynthesis in the brain. Physiol. Rev. 63 (1983) 484-546
23. Fernstrom J.D., and Faller D.V. Neutral amino acids in the brain: changes in response to food ingestion. J. Neurochem. 30 (1978) 1531-1538
24. Fernstrom M.H., and Fernstrom J.D. Acute tyrosine depletion reduces tyrosine hydroxylation rate in rat central nervous system. Life Sci. 57 (1995) 97-102
25. Figlewicz D.P., Brot M.D., McCall A.L., and Szot P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res. 736 (1996) 54-60
26. Flyckt L., Venizelos N., Edman G., Bjerkenstedt L., Hagenfeldt L., and Wiesel F.A. Aberrant tyrosine transport across the cell membrane in patients with schizophrenia. Arch. Gen. Psychiatry 58 (2001) 953-958
27. Galloway M.P., Wolf M.E., and Roth R.H. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autorceptors: studies in vivo. J. Pharmacol. Exp. Ther. 236 (1986) 689-698
28. Garris P.A., and Wightman R.M. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14 (1994) 442-450
29. Gartside S.E., Cowen P.J., and Sharp T. Evidence that the large neutral amino acid l-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo. Psychopharmacology (Berl) 109 (1992) 251-253
30. Gijsman H.J., Scarna A., Harmer C.J., McTavish S.B., Odontiadis J., Cowen P.J., and Goodwin G.M. A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function. Psychopharmacology (Berl) 160 (2002) 192-197
31. Gresch P.J., Sved A.F., Zigmond M.J., and Finlay J.M. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem. 65 (1995) 111-116
32. Gu H., Wall S.C., and Rudnick G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269 (1994) 7124-7130
33. Hagenfeldt L., Venizelos N., Bjerkenstedt L., and Wiesel F.-A. Decreased tyrosine transport in fibroblasts from schizophrenic patients. Life Sci. 41 (1987) 2749-2757
34. Harmer C.J., McTavish S.F., Clark L., Goodwin G.M., and Cowen P.J. Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology (Berl.) 154 (2001) 105-111
35. Harrison B.J., Olver J.S., Norman T.R., Burrows G.D., Wesnes K.A., and Nathan P.J. Selective effects of acute serotonin and catecholamine depletion on memory in healthy women. J. Psychopharmacol. 18 (2004) 32-40
36. Haskins J.T., Moyer J.A., Muth E.A., and Sigg E.B. DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activity. Eur. J. Pharmacol. 115 (1985) 139-146
37. Herman J.P., Guillonneau D., Dantzer R., Scatton B., Semerdjian-Rouquier L., and Le Moal M. Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci. 30 (1982) 2207-2214
38. Hilton M.A., Fonda M.L., and Hilton F.K. The effect of tyrosine-deficient total parenteral nutrition on the synthesis of dihydroxyphenylalanine in neural tissue and the activities of tyrosine and branched-chain aminotransferases. Metabolism 47 (1998) 168-176
39. Iuvone P.M., and Dunn A.J. Tyrosine hydroxylase activation in mesocortical 3,4-dihydroxyphenylethylamine neurons following footshock. J. Neurochem. 47 (1986) 837-844
40. Jaskiw G.E., Collins K.A., Pehek E.A., and Yamamoto B.K. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study. Neuropsychopharmacology 25 (2001) 149-156
41. Jaskiw G.E., Kirkbride B., Newbould E., Young D., Durkalski V., and Bongiovanni R. Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion. Psychopharmacology (Berl) 179 (2005) 713-724
42. Jaskiw G.E., Kirkbride B., and Bongiovanni R. In rats chronically treated with clozapine, tyrosine depletion attenuates the clozapine-induced in vivo increase in prefrontal cortex dopamine and norepinephrine levels. Psychopharmacology (Berl) 185 (2006) 416-422
43. Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E., and Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem. 273 (1998) 23629-23632
44. Kaufman S. In: Meister A. (Ed). Tyrosine Hydroxylase. Advances in Enzymology and Related Areas of Molecular Biology vol. 70 (1995), John Wiley & Sons Inc., New York 103-220
45. Kaufman S., and Kaufman E.E. In: Blakley R.L., and Benkovic S.J. (Eds). Tyrosine Hydroxylase. Chemistry and Biochemistry of the Pterins vol. 2 (1985), John Wiley and Sons, New York 251-352
46. Kennett G.A., and Joseph M.H. The functional importance of increased brain tryptophan in the serotonergic response to restraint stress. Neuropharmacology 20 (1981) 39-43
47. Le Masurier M., Oldenzeil W., Lehman C., Cowen P., and Sharp T. Effect of acute tyrosine depletion in using a branched chain amino-acid mixture on dopamine neurotransmission in the rat brain. NEU 31 (2006) 310-317
48. 11C) DOPA and PET. Biol. Psychiatry 46 (1999) 681-688
49. Lindvall O., and Bjorklund A. Neuroanatomical localization of dopamine in the brain and spinal cord. In: Henn F.A., and DeLisi L.E. (Eds). Neurochemistry and Neuropharmacology of Schizophrenia vol. 2 (1987), Elsevier, Amsterdam 49-99
50. Mateo Y., Pineda J., and Meana J.J. Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine. J. Neurochem. 71 (1998) 790-798
51. McTavish S.F., Cowen P.J., and Sharp T. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology (Berl.) 141 (1999) 182-188
52. Milner J.D., Reinstein D.K., and Wurtman R.J. Dopamine synthesis in rat striatum: mobilization of tyrosine from non-dopaminergic cells. Experientia 43 (1987) 1109-1110
53. Milner J.D., and Wurtman R.J. Catecholamine synthesis: physiological coupling to precursor supply. Biochem. Pharmacol. 35 (1986) 875-881
54. Miner L.H., Schroeter S., Blakely R.D., and Sesack S.R. Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. J. Comp. Neurol. 466 (2003) 478-494
55. Moran J.F., and Sourkes T.L. Multiple inhibitory effects of alpha-methylamino acids on the metabolism of C14-labeled tyrosine, DOPA and alpha-methyldopa. J. Pharmacol. Exp. Ther. 148 (1965) 252-261
56. Nakahara D., and Nakamura M. Differential effect of immobilization stress on in vivo synthesis rate of monoamines in medial prefrontal cortex and nucleus accumbens of conscious rats. Synapse 32 (1999) 238-242
57. Nielsen M. The influence of desipramine and amitriptyline on the accumulation of [3-H]noradrenaline and its two major metabolites formed from [3-H]tyrosine in the rat brain. J. Pharm. Pharmacol. 27 (1975) 207-209
58. Pardridge W.M. Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J. Neurochem. 28 (1977) 103-108
59. Pardridge W.M. Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem. Res. 23 (1998) 635-644
60. Paxinos G., and Watson D. The Rat Brain in Stereotaxic Coordinates (1982), Academic Press, New York
61. Phillips A.G., Ahn S., and Floresco S.B. Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J. Neurosci. 24 (2004) 547-553
62. Ramchand C.N., Peet M., Clark A.E., Gliddon A.E., and Hemmings G.P. Decreased tyrosine transport in fibroblasts from schizophrenics: implications for membrane pathology. Prostaglandins Leukot. Essent. Fat. Acids 55 (1996) 59-64
63. Rossetti Z.L., and Carboni S. Noradrenaline and dopamine elevations in the rat prefrontal cortex in spatial working memory. J. Neurosci. 25 (2005) 2322-2329
64. i Database (2006)
65. Schmidt R.H., and Bhatnagar R.K. Assessment of the effects of neonatal subcutaneous 6-hydroxydopamine on noradrenergic and dopaminergic innervation of the cerebral cortex. Brain Res. 166 (1979) 309-319
66. Subramanian N., and Mulder A.H. Modulation by histamine of the efflux of radiolabeled catecholamines from rat brain slices. Eur. J. Pharmacol. 43 (1977) 143-152
67. Sved A.F., and Fernstrom J.D. Tyrosine availability and dopamine synthesis in the striatum: studies with gamma-butyrolactone. Life Sci. 29 (1981) 743-748
68. Tam S.Y., Elsworth J.D., Bradberry C.W., and Roth R.H. Mesocortical dopamine neurons: high basal firing rate frequency predicts tyrosine dependence of dopamine synthesis. J. Neural Transm. 81 (1990) 97-110
69. Tanda G., Pontieri F., Frau E., and Di Chiara R. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci. 9 (1997) 2077-2085
70. Vaccaro K.K., Liang B.T., Perelle B.A., and Perlman R.L. Tyrosine 3-monooxygenase regulates catecholamine synthesis in pheochromocytoma cells. J. Biol. Chem. 255 (1980) 6539-6541
71. Valentini V., Cacciapaglia F., Frau R., and Di Chiara G. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade. J. Neurochem. 98 (2006) 113-121
72. Valentini V., Frau R., and Di Chiara G. Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. J. Neurochem. 88 (2004) 917-927
73. van Wijk M., Meisch J.J., and Korf J. Metabolism of 5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment. Psychopharmacology (Berl) 55 (1977) 217-223
74. Watanabe M., Kodama T., and Hikosaka K. Increase of extracellular dopamine in primate prefrontal cortex during a working memory task. J. Neurophysiol. 78 (1997) 2795-2798
75. Westerink B.H., and Spaan S.J. Simultaneous determination of the formation rate of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in various rat brain areas. Brain Res. 252 (1982) 239-245
76. Westerink B.H.C., and Wirix E. On the significance of tyrosine for the synthesis and catabolism of dopamine in rat brain: evaluation by HPLC with electrochemical detection. J. Neurochem. 40 (1983) 758-764
77. Westerink B.H., De Vries J.B., and Duran R. Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats. J. Neurochem. 54 (1990) 381-387
78. 11C]tyrosine and PET. J. Nucl. Med. 32 (1991) 2043-2049
79. Wiesel F.-A., Venizelos N., Bjerkenstedt L., and Hagenfeldt L. Tyrosine transport in schizophrenia. Schizophr. Res. 13 (1994) 255-258
80. Wiesel F.A., Andersson J.L., Westerberg G., Wieselgren I.M., Bjerkenstedt L., Hagenfeldt L., and Langstrom B. Tyrosine transport is regulated differently in patients with schizophrenia. Schizophr. Res. 40 (1999) 37-42
81. Wiesel F.A., Edman G., Flyckt L., Eriksson A., Nyman H., Venizelos N., and Bjerkenstedt L. Kinetics of tyrosine transport and cognitive functioning in schizophrenia. Schizophr. Res. 74 (2005) 81-89
82. Wolf M.E., Galloway M.P., and Roth R.H. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices. J. Pharmacol. Exp. Ther. 236 (1986) 699-707
83. Yamamoto B.K., and Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J. Neurochem. 71 (1998) 274-280
84. Yavich L., and MacDonald E. Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting. Brain Res. 870 (2000) 73-79